Cladis Investment Advisory, LLC Eli Lilly & CO Transaction History

Cladis Investment Advisory, LLC

$138 Billion
Q1 2025

A detailed history of Cladis Investment Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 4,644 shares of LLY stock, worth $3.52 Million. This represents 2.78% of its overall portfolio holdings.

Number of Shares

4,644

Previous 4,644 -0.0%

Holding current value

$3.52 Million

Previous $3.59 Billion 6.98%

% of portfolio

2.78%

Previous 2.54%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$727.2 - $932.06 $218,160 - $279,618	-300 Reduced 6.07%	4,644 $3.59 Billion
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $694,926 - $864,018	-900 Reduced 15.4%	4,944 $4.38 Billion
Q1 2024 Oct 09, 2024	BUY	$592.2 - $792.28 $414,540 - $554,596	700 Added 13.61%	5,844 $4.55 Billion
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $602,267 - $805,748	-1,017 Reduced 16.51%	5,144 $4 Million
Q4 2023 Oct 09, 2024	SELL	$525.19 - $619.13 $52,519 - $61,913	-100 Reduced 1.44%	6,861 $4 Billion
Q3 2023 Oct 09, 2024	BUY	$434.7 - $599.3 $789,849 - $1.09 Million	1,817 Added 35.32%	6,961 $3.74 Billion
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $19,126 - $26,369	44 Added 0.72%	6,161 $3.31 Million
Q1 2023 Oct 09, 2024	BUY	$310.63 - $364.82 $550,746 - $646,825	1,773 Added 34.47%	6,917 $2.38 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $9,318 - $10,944	30 Added 0.49%	6,117 $2.1 Million
Q4 2022 Oct 09, 2024	SELL	$321.55 - $374.67 $73,956 - $86,174	-230 Reduced 3.23%	6,887 $2.52 Billion
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $9,646 - $11,240	-30 Reduced 0.49%	6,087 $2.23 Million
Q3 2022 Oct 09, 2024	BUY	$296.48 - $337.87 $584,955 - $666,617	1,973 Added 38.36%	7,117 $2.3 Billion
Q3 2022 Nov 17, 2022	BUY	$296.48 - $337.87 $13,934 - $15,879	47 Added 0.77%	6,117 $1.98 Million
Q2 2022 Oct 09, 2024	BUY	$278.73 - $327.27 $536,833 - $630,322	1,926 Added 37.44%	7,070 $2.29 Billion
Q1 2022 Oct 08, 2024	SELL	$234.69 - $291.66 $117,345 - $145,830	-500 Reduced 6.61%	7,070 $2.02 Billion
Q4 2021 Oct 08, 2024	BUY	$224.85 - $279.04 $545,486 - $676,951	2,426 Added 47.16%	7,570 $2.09 Billion
Q4 2021 Oct 01, 2024	BUY	$224.85 - $279.04 $545,486 - $676,951	2,426 Added 47.16%	7,570 $1.68 Billion
Q4 2021 May 10, 2022	BUY	$224.85 - $279.04 $1.36 Million - $1.69 Million	6,070 New	6,070 $1.68 Million

Others Institutions Holding LLY

# of Institutions

4,380

Shares Held

822M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $720B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cladis Investment Advisory, LLC with notifications on news.

Account

Cladis Investment Advisory, LLC Eli Lilly & CO Transaction History